Tissue microarray technique in evaluation of proliferative activity in invasive ductal breast cancer

Anticancer Research

Volumn 32, Issue 3, 2012, Pages 773-777

  Kobierzycki, Christopher ^a   Pula, Bartosz ^a   Wojnar, Andrzej ^b   Podhorska Okolow, Marzena ^a   Dziegiel, Piotr ^a,c  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Dolnoslaskie Centrum Onkologii Wroclaw   (Poland)

^c UNIVERSITY OF WROC AW   (Poland)

Author keywords

Breast cancer; Ki 67; MCM 2; Tissue microarray; TMA

Indexed keywords

KI 67 ANTIGEN; MINOCHROMOSOME MAINTENANCE 2 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CLINICAL EVALUATION; COMPUTER ANALYSIS; CORRELATIONAL STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL PROLIFERATION; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; PARAFFIN EMBEDDING; TISSUE ARRAY ANALYSIS;

EID: 84858785939     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Wan WH, Fortuna MB and Furmanski P: A rapid and efficient method for testing immunohistochemical reactivity of monoclonal antibodies against multiple tissue samples simultaneously. J Immunol Methods 103: 121-129, 1987. (Pubitemid 17139428)
2. Battifora H: The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing. Lab Invest 55: 244-248, 1986.
3. Battifora H and Mehta P: The checkerboard tissue block. An improved multitissue control block. Lab Invest 63: 722-724, 1990.
4. Schoenberg Fejzo M and Slamon DJ: Frozen tumor tissue microarray technology for analysis of tumor RNA, DNA, and proteins. Am J Pathol 159: 1645-1650, 2001.
5. Li R, Ni J, Bourne PA, Yeh S, Yao J, di Sant'Agnese PA and Huang J: Cell culture block array for immunocytochemical study of protein expression in cultured cells. Appl Immunohistochem Mol Morphol 13: 85-90, 2005.
6. Datta MW, Kahler A, Macias V, Brodzeller T and Kajdacsy-Balla A: A simple inexpensive method for the production of tissue microarrays from needle biopsy specimens: Examples with prostate cancer. Appl Immunohistochem Mol Morphol 13: 96-103, 2005. (Pubitemid 40283810)
7. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G and Kallioniemi OP: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844-847, 1998. (Pubitemid 28331029)
8. Dziegiel P, Forgacz J, Suder E, Surowiak P, Kornafel J and Zabel M: Prognostic significance of metallothionein expression in correlation with Ki-67 expression in adenocarcinomas of large intestine. Histol Histopathol 18: 401-407, 2003. (Pubitemid 36362057)
9. Dziegiel P, Salwa-Zurawska W, Zurawski J, Wojnar A and Zabel M: Prognostic significance of augmented metallothionein expression correlated with Ki-67 antigen expression in selected soft tissue sarcomas. Histol Histopathol 20: 83-89, 2005. (Pubitemid 40028986)
10. Krecicki T, Jelen M, Zalesska-Krecicka M, Rak J, Szkudlarek-Gruszczynska T and Jelen-Krzeszewska J: Epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and Ki-67 antigen in laryngeal epithelial lesions. Oral Oncol 35: 180-186, 1999. (Pubitemid 29113061)
11. Ofner D, Grothaus A and Riedmann B: MIB-1 in colorectal carcinomas: its evaluation by three different methods reveals lack of prognostic significance. Anal Cell Path 12: 61-70, 1996. (Pubitemid 27007982)
12. Tungekar MF, Gatter KC, Dunnill MS and Mason DY: Ki-67 immunostaining and survival in operable lung cancer. Histopathology 19: 545-550, 1991.
13. Bettendorf O and Herremann G: Prognostic relevance of Ki-67 antigen expression in 329 cases of oral squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 64: 200-205, 2002. (Pubitemid 34621726)
14. Verheijen R, Kuijpers HJ, Schlingemann RO, Boehmer AL, van Driel R, Brakenhoff GJ and Ramaekers FC: Ki-67 detects a nuclear matrix-associated proliferation-related antigen. Intracellular localization during interphase. J Cell Sci 92: 123-130, 1989.
15. van Oijen MG, Medema RH, Slootweg PJ and Rijksen G: Positivity of the proliferation marker Ki-67 in noncycling cells. Am J Clin Pathol 110: 24-31, 1998. (Pubitemid 28294731)
16. Tye BK: Mcm proteins in DNA replication. Annu Rev Biochem 68: 649-686, 1999.
17. Kearsey SE and Labib K: MCM proteins: evolution, properties and role in DNA replication. Biochim Biophys Acta 1398: 113-136, 1998. (Pubitemid 28305206)
18. Forsburg SL: Eukaryotic MCM proteins: beyond replication initiation. Microbiol Mol Biol Rev 68: 109-131, 2004.
19. Ritzi M and Knippers R: Initiation of genome replication: assembly and disassembly of replication-competent chromatin. Gene 245: 13-20, 2000. (Pubitemid 30125359)
20. Laskey RA and Madine MA: A rotary pumping model for helicase function of MCM proteins at a distance from replication forks. EMBO Rep 4: 26-30, 2003. (Pubitemid 36305373)
21. Romanowski P and Madine MA: Mechanisms restricting DNA replication to once per cell cycle: the role of CDC 6 and ORC. Trends Cell Biol 7: 9-10, 1997. (Pubitemid 27056377)
22. Stoeber K, Mills AD, Kubota Y, Krude T, Romanowski P, Marheineke K, Laskey RA and Williams GH: Cdc6 protein causes premature entry into S-phase in a mammalian cell-free system. EMBO J 17: 7219-7229, 1998. (Pubitemid 29002691)
23. Williams RS, Shohet RV and Stilman B: A human protein related to yeast cdc6p. Proc Natl Acad Sci USA 94: 142-147, 1997. (Pubitemid 27027176)
24. Yan Z, DeGregori J, Shohet R, Leone G, Stillman B, Nevins JR and Williams RS: Cdc6 is regulated by E2F and is essential for DNA replication in mammalian cells. Proc Natl Acad Sci USA 95: 3603-3608, 1998. (Pubitemid 28173174)
25. Stoeber K, Tlsty TD, Happerfield L, Thomas GA, Romanov S, Bobrow I, Williams ED and Williams GH: DNA replication licensing and human cell proliferation. J Cell Sci 114: 2027-2041, 2001. (Pubitemid 32586628)
26. Werynska B, Pula B, Muszczynska-Bernhard B, Piotrowska A, Jethon A, Podhorska-Okolow M, Dziegiel P and Jankowska R: Correlation between expression of metallothionein and expression of Ki-67 and MCM-2 proliferation markers in non-small cell lung cancer. Anticancer Res 31: 2833-2839, 2011.
27. Wojnar A, Pula B, Piotrowska A, Jethon A, Kujawa K, Kobierzycki C, Rys J, Podhorska-Okolow M and Dziegiel P: Correlation of intensity of MT-I/II expression with Ki-67 and MCM-2 proteins in invasive ductal breast carcinoma. Anticancer Res 31: 3027-3033, 2011.
28. Wojnar A, Kobierzycki C, Krolicka A, Pula B, Podhorska-Okolow M and Dziegiel P: Correlation of Ki-67 and MCM-2 proliferative marker expression with grade of histological malignancy (G) in ductal breast cancers. Folia Histochem Cytobiol 48: 442-446, 2010.
29. Ludbrook J: Confidence in Altman-Bland plots: a critical review of the method of differences. Clin Exp Pharmacol Physiol 37(2): 143-149, 2010.
30. Ludbrook J: Statistical techniques for comparing measurers and methods of measurement: a critical review. Clin Exp Pharmacol Physiol 29(7): 527-536, 2002.
31. Camp RL, Neumeister V and Rimm DL: A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers. J Clin Oncol 26: 5630-5637, 2008.
32. Kyndi M, Sørensen FB, Knudsen H, Overgaard M, Nielsen HM, Andersen J and Overgaard J: Tissue microarrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG 82 b&c. Acta Oncol 47: 591-599, 2008. (Pubitemid 351878434)
33. Bolton KL, Garcia-Closas M, Pfeiffer RM, Duggan MA, Howat WJ, Hewitt SM, Yang XR, Cornelison R, Anzick SL, Meltzer P, Davis S, Lenz P, Figueroa JD, Pharoah PD and Sherman ME: Assessment of automated image analysis of breast cancer tissue microarrays for epidemiologic studies. Cancer Epidemiol Biomarkers Prev 19: 992-999, 2010.
34. Anagnostou VK, Lowery FJ, Syrigos KN, Cagle PT and Rimm DL: Quantitative evaluation of protein expression as a function of tissue microarray core diameter: is a large (1.5 mm) core better than a small (0.6 mm) core? Arch Pathol Lab Med 134: 613-619, 2010.
35. Karlsson C, Bodin L, Piehl-Aulin K and Karlsson MG. Tissue microarray validation: a methodologic study with special reference to lung cancer. Cancer Epidemiol Biomarkers Prev 18: 2014-2021, 2009.
36. Vogel UF and Bültmann B: Application of a novel and low cost technique to construct paraffin tissue microarrays out of paraffinised needle biopsy specimens from patients with breast cancer. J Clin Pathol 63: 640-643, 2010.
37. Munirah MA, Siti-Aishah MA, Reena MZ, Sharifah NA, Rohaizak M, Norlia A, Rafie MK, Asmiati A, Hisham A, Fuad I, Shahrun NS and Das S: Identification of different subtypes of breast cancer using tissue microarray. Rom J Morphol Embryol 52: 669-677, 2011.